Invitation: On Augusα÷↓t 15-16, 2024, Haibu Pharmaceutical‌   invites you to gather in Suzhou for tγ•he 6th CMC-China Expo.

Beijing Haibu Pharmac✘π£↕eutical Technology Co., Ltd.  ≤ (referred to as "Haibu Pharmaceutical"≤γ) was established in 2005 a€& αnd is a high-tech enterprise with↓&§© "chemical drug research and devπ‍≠Ωelopment" as its core capabi"™δlity. It has a research an ​£'d development center in Beijing, aσ← pilot verification center for raw mate§↑"×rials and formulations, and aδ π GMP industrial productiσβ₩on base, mainly engaged in CRO service®αs for raw materials  ♦♦ and formulations, MA$Ω☆H joint licensing, related applicat≠↑ions for raw materials, and commercial ↓±₩supply of pharmaceutical intermediates$✘.It has rich experience₹≥ in the research and production transfeα™r, registration applic$←¶ation, etc., of various dosage f₽<'✘orms such as chemical raw★® materials, oral solidsγ‍←β, liquid preparations, sterile inje£€>Ωctions, and external ★¥βpreparations. The R& ✘€D products cover multiple t&←♦herapeutic areas including anti-tumor,±← anti-depression, anti-epilepsy, anti' -anxiety, cardiovascular and cerebro✔©vascular diseases, digestiveβ♠‍ system disorders, resεδ™γpiratory system issues,±α etc.

Haibu Pharmaceutical has been awarded ‍ the title of "Top 2Ωσ♠γ0 Chinese Pharmaceutic♦÷'al R&D Companies" § φ¶for several consecutive yea£ rs and has been recognized as a "Speλ$cialized and Innovative"÷≥φ enterprise in Beijing, a ♥←©"National High-tech Enterprise", a✘♦≥ "Beijing Science and Technology Researλ‌ch Development Insti€☆ tution", and a "Beijing Yizhuang Ente≠ rprise Innovation Center", among othe•≠rs.